Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jan 2025 for ALNYLAM PHARMACEUTICALS, INC., €1.4M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Phillip A. Sharp: trading record in brief
Phillip A. Sharp, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Alnylam Pharmaceuticals, Inc. and Vir Biotechnology, Inc. We count 7 filings; the first trade dates from 21 May 2021 and the latest from 23 January 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 24 January 2025 with an option exercise (€1.4M) in Alnylam Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Phillip A. Sharp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
11,250 shares@ US$131.2131.2% of flowCommon StockSEC:0001735276-25-000002:0
30,000 shares@ US$59.2536.1% of flowCommon StockSEC:0001735276-24-000022:0
6,027 shares0Common StockSEC:0001209191-23-031842:0
30,000 shares@ US$30.0919.6% of flowCommon StockSEC:0001735276-22-000069:0
6,405 shares0Common StockSEC:0001209191-22-031961:0
30,000 shares@ US$11.337.0% of flowCommon StockSEC:0001735276-22-000014:0
3,374 shares0Common StockSEC:0001209191-21-035716:0
7 of 7 declarations
